Shalvata Mental Health Center: Clinical Trials

75 trials sponsored by Shalvata Mental Health Center, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

53 unknown, 15 completed, 4 recruiting, 1 active not recruiting. 38 Not applicable, 10 Phase 1, 8 Phase 2, 3 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable38Unknown 32, Completed 6
Phase 110Unknown 6, Completed 4
Phase 28Unknown 7, Completed 1
Phase 33Completed 1, Not yet recruiting 1, Recruiting 1
Phase 42Completed 1, Unknown 1

Follow Shalvata Mental Health Center: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Stratification and Treatment in Early Psychosis Study -ASSIST
CBD 100 mg/mL Oral Solution, Placeb - Treatment Resistant Psychosis, Psychosis
Phase 3Not yet recruitingUniversity of Oxford2502027-01-012026-10-08
Stratification and Treatment in Early Psychosis Study - ENHANCE
CBD 100 mg/mL Oral Solution, Placebo - Psychosis, First Episode Psychosis
Phase 3RecruitingUniversity of Oxford2502026-10-052026-10-08
Psychotherapy Expectations and Distress Among Mental Health Patients and Their Therapists.
Expectancy, Distress, Psychological
RecruitingShalvata Mental Health Center1002025-02-202025-05-02
Mechanisms and Outcomes of Children and Adolescent Psychotherapy
Mental Health
RecruitingShalvata Mental Health Center300002025-01-052026-07-29
Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections: Translating Epidemiology to Deep-phenotyping.
Anxiety, Depression - Major Depressive Disorder
Active not recruitingShalvata Mental Health Center1000002024-08-172026-07-23
Oxytocin Administration to Therapists and Its Effects on Patient-perceived Attunement and Responsiveness
Oxytocin nasal spray - Mental Health Therapists
Phase 1UnknownShalvata Mental Health Center202024-05-012024-03-27
The Predictive Role of Immune-inflammatory Biomarkers and Their Interaction With the Oxytocin System in Trauma-related Psychotherapy Responsiveness
Posttraumatic Stress Disorder
RecruitingShalvata Mental Health Center1002024-03-142024-06-28
The Moderating Role of Baseline Oxytocin on Its Psychotherapy-facilitating Effects Among Patients With Eating Disorders
Oxytocin nasal spray - Eating Disorders
Phase 1UnknownShalvata Mental Health Center902023-06-302023-05-18
The Effects of Oxytocin Administration to Patients and Therapists on Physiological Synchronization
Intranasal Oxytocin - Severe Mental Illness
Phase 2UnknownShalvata Mental Health Center1202023-03-302024-06-28
Sensory Hyperstimulation for Treating Depression
sensory hyperstimulation - Depressive Disorder
Not applicableCompletedShalvata Mental Health Center152021-04-182026-09-02
Optimizing the Resources of Psychotherapy as a Tool for Implementing the Mental Health Reform
Supervision assissted by measures - Psychotherapy Research and Outcome Measures
Not applicableUnknownShalvata Mental Health Center802020-10-012019-07-12
Assessing the Effect of Compensatory Cognitive Intervention Among People With Severe Mental Illness
compensatory cognitive treatment - Mood Disorders, Schizophrenia
Not applicableUnknownShalvata Mental Health Center602020-09-012020-09-17
Using Clinical Process Indicators, Patient Reported Outcome Measures (PROMs), and Patient Reported Experience Measures (PREMs) to Improve the Quality and Continuity of Care for Psychiatric Patients
Monitoring PROM @ PREM data on participating patients - Severe Mental Illness, Rehabilitation
UnknownShalvata Mental Health Center1252020-04-152020-03-19
Assessment of Cost-effectiveness in Two Empirically-based Psychotherapies for Borderline Personality Disorder: A Randomized Controlled Trial
DBT, DDP, control group - Treatment 1:Dialectical Behavior Therapy (DBT), Treatment 2:Dynamic Deconstructive Psychotherapy (DDP)
Not applicableUnknownShalvata Mental Health Center602020-04-012020-03-16
Optimizing Outcomes of Dynamic Psychotherapy by the MATRIX: A Preliminary Study
Routine outcome measures (ROM) - Psychotherapy, Mental Health
Not applicableUnknownShalvata Mental Health Center202019-01-012019-01-23
Doing More With Less": Optimizing Psychotherapeutic Services in the Mental Health System
questionnaires - Anxiety Disorder, Affective Disorders
Not applicableUnknownShalvata Mental Health Center1002018-09-012018-08-01
Intranasal Oxytocin as Enhancer of Psychotherapy Outcomes in Severe Mental Illness
Intranasal Oxytocin, Intranasal Placebo - Severe Mental Illness
Phase 2UnknownShalvata Mental Health Center1202018-06-012024-06-28
Evaluation of the H1-Coil TMS- Double Blind Placebo Controlled Study in Adolescent Patients Suffering From Major Depression
Deep TMS Brainsway's H coil - Depression
Not applicableUnknownShalvata Mental Health Center522018-05-012018-05-30
dTMS as a Treatment for Patients With Fibromyalgia
prefrontal deep rTMS of H1 Coil - Studying Efficacy of dTMS in FM
Not applicableUnknownShalvata Mental Health Center402018-04-012018-03-09
The Experience of Older Adults Facing Depression for the First Time in Old Age
Interview - MAjor Depressive Disorder
UnknownShalvata Mental Health Center152017-03-012017-01-04

Showing 20 of 75. Sign in to see all of them.

Conditions studied

Schizophrenia (17)  ·  Depression (13)  ·  Attention Deficit Disorder with Hyperactivity (10)  ·  Anxiety Disorders (9)  ·  Psychotic Disorders (8)  ·  Depressive Disorder, Major (5)  ·  Mental Disorders (5)  ·  Bipolar Disorder (4)  ·  Mood Disorders (3)  ·  Personality Disorders (3)  ·  Stress Disorders, Post-Traumatic (3)  ·  Behavior (2)  ·  Borderline Personality Disorder (2)  ·  Depressive Disorder (2)  ·  Fibromyalgia (2)

Interventions

Methylphenidate (7)  ·  Minocycline (3)  ·  5,10-dihydro-5-methylphenazine (2)  ·  Solutions (2)  ·  Buprenorphine (1)  ·  Control Groups (1)  ·  Electroencephalography (1)  ·  Interviews as Topic (1)  ·  Ketamine (1)  ·  Magnetoencephalography (1)  ·  Neuropsychological Tests (1)  ·  Olanzapine (1)  ·  Oxytocin (1)  ·  Sodium Chloride (1)  ·  Surveys and Questionnaires (1)

Countries

Israel (64)  ·  Germany (2)  ·  Greece (2)  ·  Italy (2)  ·  Netherlands (2)  ·  Spain (2)  ·  Switzerland (2)  ·  United Kingdom (2)  ·  Austria (1)

Top investigators

Aviv Segev, MD (4)  ·  Eiran V Harel, MD (3)  ·  Yechiel Levkovitz, MD, PhD (3)  ·  Yuval Bloch, MD (2)  ·  Abraham Zangen, Ph.D. (1)  ·  Eiran Vadim Harel, MD (1)  ·  Evelyn Steiner, MD (1)  ·  Hagai Harari, MD (1)  ·  Hagai Maoz, MD (1)  ·  Hilik Levkovits (1)  ·  Hilik Levkovitz, MD. (1)  ·  Hilik Levkovitz, Prof. (1)  ·  Hilik Levkovitz, Professor (1)  ·  Hilik Levkovitz, prof. (1)

Results publications

PMID 19895780, PMID 20521875, PMID 20854181, PMID 31156406, PMID 36905736, PMID 36971690, PMID 41342306

NIH funding

2025 (1)